The FDA has approved Cobenfy, a dual M1/M4 muscarinic agonist that offers a fundamentally different approach to treating ...

The promising drug combination was discovered and tested by Karuna Therapeutics, which Bristol Myers Squibb acquired in March. Bristol Myers Squibb will sell the drug combination under the brand name ...

A medicine that sidesteps the brain's dopamine receptors to reach different targets represents a new approach to ...

The FDA has approved the first treatment for schizophrenia that targets cholinergic receptors rather than dopamine receptors.

Bristol Myers Squibb received U.S. Food and Drug Administration (FDA) approval on Thursday for its groundbreaking ...

Bristol-Myers Squibb's acquisition of Karuna and FDA approval of Cobenfy signal growth potential, with focus on driving ...

Roche's oral anti-obesity candidate outperformed a similar candidate from Viking Therapeutics in terms of efficacy. Viking Therapeutics' oral anti-obesity candidate appears much easier to tolerate ...

The funding aims at supporting further advancements on the Coventry-based firms technology platform to accelerate the development of biologic therapeutics. Funding was co-led by BGF, Octopus ...

Actress Karuna Pandey, known for her role in Pushpa Impossible, shares her journey from learning Bharatnatyam and Kathak to pursuing a degree in Performing Arts. Despite the pressures of social ...

Seven jobs will be cut at Coventry University following a review into its Centre for Peace and Security. The centre contributes to work on human security, peace studies and social relations ...

Teachers' Day celebrates educators' pivotal role in shaping futures. Artists recount how their teachers profoundly impacted their lives and careers. They highlight lessons of independence ...

Karuna Pandey, who portrays the character of Pushpa in Pushpa Impossible, said, “There are many lessons I've learned over the years, but one that stands out is from when I was in 9th standard.